Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

NCT03737643 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1407

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Ovarian Cancer

Interventions

DRUG: Bevacizumab
DRUG: Durvalumab
DRUG: Olaparib
DRUG: Placebo olaparib
DRUG: Durvalumab placebo
DRUG: Carboplatin+Paclitaxel

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]
[object Object]